Inspira Technologies Oxy BHN (IINN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Inspira Technologies Oxy BHN is innovating the respiratory support market with its INSPIRA ART technology, aiming to replace conventional mechanical ventilators. The company has received FDA clearance for its INSPIRA ART 100 system, which promises a significant impact on the $19 billion mechanical ventilation market by offering rapid oxygenation without the need for invasive procedures. As the demand for respiratory support grows, driven by ICU admissions and conditions like COVID-19, Inspira’s advancements could revolutionize patient care.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.